Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 9,142 | 23,371 | 23,525 | 31,869 | 12,993 |
| Depreciation Amortization | -621 | -119 | -69 | -3,543 | -3,169 |
| Accounts receivable | 1,474 | 1,234 | 1,147 | 329 | 80 |
| Accounts payable and accrued liabilities | -434 | -853 | -804 | -297 | -36 |
| Other Working Capital | -69,010 | -65,676 | -47,588 | -126,415 | -84,958 |
| Other Operating Activity | 7,105 | 5,247 | 2,746 | 11,826 | 8,767 |
| Operating Cash Flow | $-52,344 | $-36,796 | $-21,043 | $-86,231 | $-66,323 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -45,306 | -45,618 | 30,715 | 100,010 | 84,795 |
| PPE Investments | -19 | -146 | -119 | -310 | -230 |
| Investing Cash Flow | $-45,325 | $-45,764 | $30,596 | $99,700 | $84,565 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 93,803 | 93,550 | N/A | 7,522 | 5,273 |
| Financing Cash Flow | $93,803 | $93,550 | $N/A | $7,522 | $5,273 |
| Beginning Cash Position | 39,079 | 39,079 | 39,079 | 18,088 | 18,088 |
| End Cash Position | 35,213 | 50,069 | 48,632 | 39,079 | 41,603 |
| Net Cash Flow | $-3,866 | $10,990 | $9,553 | $20,991 | $23,515 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,344 | -36,796 | -21,043 | -86,231 | -66,323 |
| Capital Expenditure | -19 | -146 | -119 | -310 | -230 |
| Free Cash Flow | -52,363 | -36,942 | -21,162 | -86,541 | -66,553 |